Search results
Some Berkshire Hathaway investors tried buying the dip during Monday’s glitch — but ended up with...
MarketWatch via Yahoo Finance· 3 days agoMany investors likely tried to buy what appeared to be a more than 99% dip in Berkshire Hathaway...
3 High-Yield Dividend Stocks to Buy in June to Safeguard Your Portfolio From Future Storms | The...
The Motley Fool· 14 hours agoThe stock market has been red-hot over the past year, setting several new all-time highs. Here's why...
Warren Buffett Accumulated Most of His Wealth After Age 65. Here's Why That's Great News for Your...
The Motley Fool via AOL· 4 days agoIf you don't, though, it's not a problem. Buffett himself has long suggested that the average...
Glitch Gives Warren Buffett Stock Investors A $600,000 Scare
Investor's Business Daily· 5 days agoET at a price of around 640,000, Barron's reported. The lower priced Berkshire Hathaway Class B...
Why Cisco’s AI News Didn’t Inspire The Market
Forbes· 3 days agoCisco executives were working overtime this week to make the case that Cisco shares are an AI play for investors. At its Cisco Live annual conference in...
Sea Limited's Gaming Business Marched Ahead With Its Turnaround Efforts
Motley Fool via Yahoo Finance· 4 days agoFortunately, Sea Limited's Q1 2024 earnings gave investors hope that the positive momentum...2024....
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 22 hours agoNEW YORK, June 08, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of QuidelOrtho Corporation (NASDAQ: ...
Social equity in Arizona’s cannabis program failed, critics say
Arizona Daily Star· 14 hours agoAfter Cookies opened last June, owner Alicia Deals became one of the few remaining social equity...
The Income Investor's Dream Team: 7 Sturdy Dividend Stocks Yielding 6%
InvestorPlace· 5 days agoThe most obvious reason investors should buy high-yield dividend stocks is that they provide income....
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 2 days agoPfizer is not hitting those marks. Big institutional investors — who account for up to 70% of all...